Literature DB >> 21390966

HIV vaccine acceptability and culturally appropriate dissemination among sexually diverse Aboriginal peoples in Canada.

P A Newman1, M R Woodford, C Logie.   

Abstract

This study explored HIV vaccine acceptability and strategies for culturally appropriate dissemination among sexually diverse Aboriginal peoples in Canada, among those at highest HIV risk. We conducted four focus groups (n=23) with Aboriginal male (1) and female (1) service users, peer educators (1) and service providers (1) in Ontario, Canada. Transcripts were analysed with narrative thematic techniques from grounded theory, using NVivo. Participants' mean age was 37 years; about half (52%) were female, half (48%) Two-spirit or lesbian, gay or bisexual (LGB)-identified, 48% had a high-school education or less and 57% were unemployed. Vaccine uptake was motivated by community survival; however, negative HIV vaccine perceptions, historically based mistrust of government and healthcare institutions, perceived conflict between western and traditional medicine, sexual prejudice and AIDS stigma within and outside of Aboriginal communities, and vaccine cost may present formidable obstacles to HIV vaccine acceptability. Culturally appropriate processes of engagement emerged on individual levels (i.e., respect for self-determination, explanations in Native languages, use of modelling and traditional healing concepts) and community levels (i.e., leadership by Aboriginal HIV advocates and political representatives, identification of gatekeepers, and procuring Elders' endorsements). Building on cultural strengths and acknowledging the history and context of mistrust and social exclusion are fundamental to effective HIV vaccine dissemination.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21390966     DOI: 10.1080/17441692.2010.549139

Source DB:  PubMed          Journal:  Glob Public Health        ISSN: 1744-1692


  11 in total

1.  Drug users' willingness to encourage social, sexual, and drug network members to receive an HIV vaccine: a social network analysis.

Authors:  A M Young; R J DiClemente; D S Halgin; C E Sterk; J R Havens
Journal:  AIDS Behav       Date:  2014-09

2.  Perceptions of sexual risk compensation following posttrial HIV vaccine uptake among young South Africans.

Authors:  Catherine L Macphail; Jennifer N Sayles; William Cunningham; Peter A Newman
Journal:  Qual Health Res       Date:  2012-01-04

Review 3.  Combination HIV prevention interventions: the potential of integrated behavioral and biomedical approaches.

Authors:  Jennifer L Brown; Jessica M Sales; Ralph J DiClemente
Journal:  Curr HIV/AIDS Rep       Date:  2014-12       Impact factor: 5.071

4.  Use of conjoint analysis to assess HIV vaccine acceptability: feasibility of an innovation in the assessment of consumer health-care preferences.

Authors:  S J Lee; P A Newman; W S Comulada; W E Cunningham; N Duan
Journal:  Int J STD AIDS       Date:  2012-04       Impact factor: 1.359

5.  Towards a Science of Community Stakeholder Engagement in Biomedical HIV Prevention Trials: An Embedded Four-Country Case Study.

Authors:  Peter A Newman; Clara Rubincam; Catherine Slack; Zaynab Essack; Venkatesan Chakrapani; Deng-Min Chuang; Suchon Tepjan; Murali Shunmugam; Surachet Roungprakhon; Carmen Logie; Jennifer Koen; Graham Lindegger
Journal:  PLoS One       Date:  2015-08-21       Impact factor: 3.240

6.  Adapting and validating a scale to measure sexual stigma among lesbian, bisexual and queer women.

Authors:  Carmen H Logie; Valerie Earnshaw
Journal:  PLoS One       Date:  2015-02-13       Impact factor: 3.240

7.  Acceptability of a hypothetical preventative HIV vaccine among people who use drugs in Vancouver, Canada.

Authors:  Taylor Fleming; Jenna Valleriani; Cara Ng; Lisa Maher; Will Small; Ryan McNeil
Journal:  BMC Public Health       Date:  2020-07-09       Impact factor: 3.295

8.  "Why Don't You Go Into Suburbs? Why Are You Targeting Us?": Trust and Mistrust in HIV Vaccine Trials in South Africa.

Authors:  Siyabonga Thabethe; Catherine Slack; Graham Lindegger; Abigail Wilkinson; Douglas Wassenaar; Philippa Kerr; Linda-Gail Bekker; Kathy Mngadi; Peter A Newman
Journal:  J Empir Res Hum Res Ethics       Date:  2018-12       Impact factor: 1.742

9.  Gender and ethnicity differences in HIV-related stigma experienced by people living with HIV in Ontario, Canada.

Authors:  Mona R Loutfy; Carmen H Logie; Yimeng Zhang; Sandra L Blitz; Shari L Margolese; Wangari E Tharao; Sean B Rourke; Sergio Rueda; Janet M Raboud
Journal:  PLoS One       Date:  2012-12-27       Impact factor: 3.240

10.  HIV vaccine acceptability among high-risk drug users in Appalachia: a cross-sectional study.

Authors:  April M Young; Ralph J DiClemente; Daniel S Halgin; Claire E Sterk; Jennifer R Havens
Journal:  BMC Public Health       Date:  2014-05-30       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.